Achieve manufacturing excellence, optimise processes and reduce costs

Now in its 12th year, the World Drug Manufacturing Summit provides the key tools to overcome the biggest threats facing pharma manufacturers today.

World Drug Manufacturing  2013 focuses on achieving process and manufacturing excellence, process re-engineering, six sigma tools to reduce variability, with specific case studies on continuous improvement, successful QbD implementations, real time data collection, analysis, knowledge management and much more.

Key themes for 2013 include:

• Process excellence – achieving real process flow vs. functional silo’s
• Optimising process re-engineering vs. opex to achieve improvement
• Responding to price pressures and stricter regulatory requirements
• Addressing anti counterfeiting regulations and their impact on production
• Satisfying the 1st serialisation directive
• Innovation in total cost reduction vis-a-vis health care reform and the financial crisis
• Implementing continuous manufacturing technology throughout operations
• Making effective decisions on where to manufacture new products

View the full programme

Drug manufacturers want to understand the real benefits of becoming a process flow organisations as the basis for manufacturing excellence vs. the functional silo organisations which have been a barrier to continuous improvement.

The need to change mindsets, improve manufacturing strategies, reduce costs and satisfy regulators as the industry comes under fire from price pressures and healthcare reform, is key at this time. The WDM summit provides in-depth answers, insights and case studies from industry leaders.

If you have any questions about this upcoming programme, or would like to speak or propose a paper at WDM 2013 please contact Dora Walsh on +44 (0) 20 7202 7695 or at dora.walsh@wtgevents.com

Book your place today